Thyroid Function in End Stage Renal Disease and Effects of Frequent Hemodialysis

Overview

Journal Hemodial Int

Date 2017 Mar 17

PMID 28301073

Citations 7

Authors

Joan C Lo

Gerald J Beck

George A Kaysen

Christopher T Chan

Alan S Kliger

Michael V Rocco

Minwei Li

Glenn M Chertow

Affiliations

Soon will be listed here.

Abstract

Introduction: End-stage renal disease (ESRD) is associated with perturbations in thyroid hormone concentrations and an increased prevalence of hypothyroidism. Few studies have examined the effects of hemodialysis dose or frequency on endogenous thyroid function.

Methods: Within the Frequent Hemodialysis Network (FHN) trials, we examined the prevalence of hypothyroidism in patients with ESRD. Among those with endogenous thyroid function (without overt hyper/hypothyroidism or thyroid hormone supplementation), we examined the association of thyroid hormone concentration with multiple parameters of self-reported health status, and physical and cognitive performance, and the effects of hemodialysis frequency on serum thyroid stimulating hormone (TSH), free thyroxine (FT4), and free tri-iodothyronine (FT3) levels. Conventional thrice-weekly hemodialysis was compared to in-center (6 d/wk) hemodialysis (Daily Trial) and Nocturnal (6 nights/wk) home hemodialysis (Nocturnal Trial) over 12 months.

Findings: Among 226 FHN Trial participants, the prevalence of hypothyroidism was 11% based on thyroid hormone treatment and/or serum TSH ≥8 mIU/mL. Among the remaining 195 participants (147 Daily, 48 Nocturnal) with endogenous thyroid function, TSH concentrations were modestly (directly) correlated with age (r = 0.16, P = 0.03) but not dialysis vintage. Circulating thyroid hormone levels were not associated with parameters of health status or physical and cognitive performance. Furthermore, frequent in-center and nocturnal hemodialysis did not significantly change (baseline to month 12) TSH, FT4, or FT3 concentrations in patients with endogenous thyroid function.

Discussion: Among patients receiving hemodialysis without overt hyper/hypothyroidism or thyroid hormone treatment, thyroid indices were not associated with multiple measures of health status and were not significantly altered with increased dialysis frequency.

Citing Articles

A Comparative Study of Euthyroid and Primary Hypothyroid Patients in End Stage Renal Disease (ESRD) Undergoing Maintenance Hemodialysis (MHD) in a Tertiary Care Hospital in Salem, Tamil Nadu.

Vijayasamundeeswari C, Jayachandrababu B, Kundu S, Parhi K, Ronald P, Periasamy P J Pharm Bioallied Sci. 2025; 16(Suppl 5):S4555-S4558.

PMID: 40061716 PMC: 11888765. DOI: 10.4103/jpbs.jpbs_1221_24.

Immune Reconstitution After Total Parathyroidectomy and Forearm Transplantation in Chronic Renal Failure.

Ren T, Zhong T, Yang F, Liao X, Yang M, Ji L J Craniofac Surg. 2024; 36(1):e12-e16.

PMID: 39560955 PMC: 11658055. DOI: 10.1097/SCS.0000000000010713.

De Novo Cancer Incidence after Kidney Transplantation in South Korea from 2002 to 2017.

Kim B, Kang M, Kim Y, Lee H, Kim B, Lee J J Clin Med. 2021; 10(16).

PMID: 34441826 PMC: 8396914. DOI: 10.3390/jcm10163530.

Thyroid Pathology in End-Stage Renal Disease Patients on Hemodialysis.

Cotoi L, Borcan F, Sporea I, Amzar D, Schiller O, Schiller A Diagnostics (Basel). 2020; 10(4).

PMID: 32340182 PMC: 7236006. DOI: 10.3390/diagnostics10040245.

A five-year longitudinal study of the relation between end-stage kidney disease as the outcomes.

Li H, Tai P, Hwang Y, Lin S BMC Nephrol. 2020; 21(1):132.

PMID: 32295526 PMC: 7161172. DOI: 10.1186/s12882-020-01795-9.

References

Beck A, Ward C, Mendelson M, Mock J, ERBAUGH J . An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4:561-71. DOI: 10.1001/archpsyc.1961.01710120031004. View

Hays R, Morales L . The RAND-36 measure of health-related quality of life. Ann Med. 2001; 33(5):350-7. DOI: 10.3109/07853890109002089. View

Craven J, Rodin G, Johnson L, Kennedy S . The diagnosis of major depression in renal dialysis patients. Psychosom Med. 1987; 49(5):482-92. DOI: 10.1097/00006842-198709000-00005. View

Furlong W, Feeny D, Torrance G, Barr R . The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med. 2001; 33(5):375-84. DOI: 10.3109/07853890109002092. View

Molitch M, Hou S . Neuroendocrine alterations in systemic disease. Clin Endocrinol Metab. 1983; 12(3):825-51. DOI: 10.1016/s0300-595x(83)80066-8. View

Zoccali C, Mallamaci F . Thyroid function and clinical outcomes in kidney failure. Clin J Am Soc Nephrol. 2011; 7(1):12-4. DOI: 10.2215/CJN.12081111. View

Paudel K . Prevalence and clinical characteristics of hypothyroidism in a population undergoing maintenance hemodialysis. J Clin Diagn Res. 2014; 8(4):MC01-4. PMC: 4064857. DOI: 10.7860/JCDR/2014/7821.4246. View

Xu H, Brusselaers N, Lindholm B, Zoccali C, Carrero J . Thyroid Function Test Derangements and Mortality in Dialysis Patients: A Systematic Review and Meta-analysis. Am J Kidney Dis. 2016; 68(6):923-932. DOI: 10.1053/j.ajkd.2016.06.023. View

Rhee C, Kalantar-Zadeh K, Streja E, Carrero J, Ma J, Lu J . The relationship between thyroid function and estimated glomerular filtration rate in patients with chronic kidney disease. Nephrol Dial Transplant. 2014; 30(2):282-7. PMC: 4309193. DOI: 10.1093/ndt/gfu303. View

10.

Lim V . Thyroid function in patients with chronic renal failure. Am J Kidney Dis. 2001; 38(4 Suppl 1):S80-4. DOI: 10.1053/ajkd.2001.27410. View

11.

Lim V, Fang V, Katz A, Refetoff S . Thyroid dysfunction in chronic renal failure. A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine. J Clin Invest. 1977; 60(3):522-34. PMC: 372397. DOI: 10.1172/JCI108804. View

12.

Ramirez G, ONeill Jr W, Jubiz W, BLOOMER H . Thyroid dysfunction in uremia: evidence for thyroid and hypophyseal abnormalities. Ann Intern Med. 1976; 84(6):672-6. DOI: 10.7326/0003-4819-84-6-672. View

13.

Zoccali C, Benedetto F, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P . Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease. J Hypertens. 2006; 24(10):2039-46. DOI: 10.1097/01.hjh.0000244954.62362.8f. View

14.

Alsaran K, Sabry A, Alshahhat H, Babgy E, Alzahrani F . Free thyroxine, free triiodothyronine and thyroid-stimulating hormone before and after hemodialysis in Saudi patients with end-stage renal disease: is there any difference?. Saudi J Kidney Dis Transpl. 2011; 22(5):917-21. View

15.

Lo J, Chertow G, Go A, Hsu C . Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int. 2005; 67(3):1047-52. DOI: 10.1111/j.1523-1755.2005.00169.x. View

16.

Rhee C, Alexander E, Bhan I, Brunelli S . Hypothyroidism and mortality among dialysis patients. Clin J Am Soc Nephrol. 2012; 8(4):593-601. PMC: 3613957. DOI: 10.2215/CJN.06920712. View

17.

van Leusen R, Meinders A . Cyclical changes in serum thyroid hormone concentrations related to hemodialysis: movement of hormone into and out of the extravascular space as a possible mechanism. Clin Nephrol. 1982; 18(4):193-9. View

18.

Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P . Low triiodothyronine and survival in end-stage renal disease. Kidney Int. 2006; 70(3):523-8. DOI: 10.1038/sj.ki.5001566. View

19.

Rhee C, Kim S, Gillen D, Oztan T, Wang J, Mehrotra R . Association of thyroid functional disease with mortality in a national cohort of incident hemodialysis patients. J Clin Endocrinol Metab. 2015; 100(4):1386-95. PMC: 4399303. DOI: 10.1210/jc.2014-4311. View

20.

Hegedus L, Andersen J, Poulsen L, Perrild H, Holm B, Gundtoft E . Thyroid gland volume and serum concentrations of thyroid hormones in chronic renal failure. Nephron. 1985; 40(2):171-4. DOI: 10.1159/000183455. View